Sanofi Consumer Healthcare India Limited (SCHIL) has announced its successful listing on BSE Limited (BSE- formerly known as Bombay Stock Exchange) and National Stock Exchange of India Limited (NSE). The milestone was marked with the ringing of the opening bell at BSE by Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, signifying the listing of the company’s Equity Shares.

Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited said, “India’s consumer healthcare market has vast potential. SCHIL getting listed on BSE and NSE marks a critical milestone for us; one that is further expected to strengthen our position and drive sustainable growth within the Indian market. By evaluating our business needs, capitalising on emerging consumer trends in the healthcare space and encouraging a culture of digital innovations, we seek to address unmet consumer needs. For this, we aim to enhance our customer experience with our products."

SCHIL has emerged as a distinct legal entity following its demerger from Sanofi India Limited. This demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on 1st June 2024.

In alignment with Sanofi's global strategy, SCHIL is now operating independently, with a dedicated focus on the Consumer Healthcare sector. Leveraging its global experience in consumer healthcare, it aims to enhance customer wellbeing through its portfolio of products which encompasses Allergy, Digestive Wellness, Pain Care, and Multivitamins and Herbal/Traditional Dietary Supplements.